Daewoong Pharmaceutical Co. Ltd.

This study tracks 200 adults with type 2 diabetes who are prescribed enavogliflozin (alone or with other diabetes drugs) to see how much weight they lose over 24 weeks. Researchers measure changes in body weight and BMI at 12 and 24 weeks. The goal is to understand the drug's rea…

This study looks at how well Envlo or Envlomet SR tablets control blood sugar in 15,000 adults with type 2 diabetes over 24 weeks. Participants take the medicine as part of their normal care. The goal is to see if these tablets safely lower blood sugar levels.

This study looks at whether a mobile app called 'Well Check' can help people with type 2 diabetes better control their blood sugar, blood pressure, and weight. About 471 adults who are starting a new diabetes medication will use the app, which connects to their electronic health …